They have concluded that PRP improved healing and is an effective treatment for pain.
There has been a Cochrane Review of PRP in the treatment of chronic wound that has not shown conclusive evidence that PRP is effective. [2] This paper, however, describes the first use of PRP in Buerger's disease. PRP is a term that describes plasma concentrate that is rich in platelets, although centrifugation is the most common method of preparing PRP, [3] there is currently no standardized preparation technique.
This has led to the classification of PRP with two main key parameters -presence of cell contents and fibrin architecture. [4] Depending on the preparation method used, one of four family of PRP can be produced. Hence, not all PRPs are the same; therefore, outcome comparison can be difficult.
The authors classified cases according to the Rutherford and Society for Vascular Surgery (SVS) WIfI system. The concept of using WIfI for Buerger's disease is new as Buerger's disease is not included in the SVS WIfI system. [5] The authors argued that the factors present in threatened diabetic foot infection also present in Buerger's disease, hence the utilization of it. This study, however, did not demonstrate a correlation between WIfI classification and the outcome; it is, however, worth bearing in mind that this is a pilot study with a small sample size.
Two main aspects of the study relate to ulcer healing and pain relive. The severity of pain was recorded on a visual analog scale. Pain score was recorded on day 1, 5, and 10 but assumed to be at a maximum of 10 on day 0. The improvement of pain was measured against this baseline. There is an inherent bias in this method resulting in the over estimation of the analgesic effect of PRP.
With regards to ulcer healing, a grading system of 25 percentage point was used to measure healing. This method is simpler, one wonders if objective measurement of ulcer size, that is, surfaced area would have provided more detailed data for analysis.
The link between smoking and Buerger's disease is well documented. [6] The effect of Buerger's disease is more profound in South Asia where young patients are disproportionally affected within a challenging health economics. The prospect of a nonsurgical, autologous biological treatment, which can be administered in an outpatient setting, should be explored with enthusiasm. This pilot study concluded positive outcome for both wound healing and pain reduction, it is hope that this can be confirmed in larger study and demonstrates the benefit of PRP in addition to smoking cessation.
